Showing results (271-280 of 281) with videos related to
Sort By:
Pageof 29
Gene Therapy|September 1, 1999
A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agentsJ Jelinek, J A Rafferty, R Cmejla, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1994
Dose-escalating induction chemotherapy supported by lenograstim preceding high-dose consolidation chemotherapy for advanced breast cancer. Selection of the most acceptable regimen to induce maximal tumor response and investigation of the optimal time to collect peripheral blood progenitor cells for haematological rescue after high-dose consolidation chemotherapyM E Van Hoef, I Baumann, C Lange, et al.Gene Therapy|January 1, 1997
Uptake of alpha-(L)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitroK Stewart, O A Brown, A E Morelli, et al.Bone Marrow Transplantation|May 1, 1997
Autografting in Philadelphia (Ph)+ chronic myeloid leukaemia using cultured marrow: an update of a pilot studyL H Coutinho, J Chang, M L Brereton, et al.Blood|October 15, 1995
Clonal hematopoiesis as defined by polymorphic X-linked loci occurs infrequently in aplastic anemiaA Raghavachar, J W Janssen, H Schrezenmeier, et al.European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010E Marshall, A H Howell, R Powles, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancerA Weaver, J Chang, E Wrigley, et al.Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrowL J Fairbairn, L S Lashford, E Spooncer, et al.Blood|December 15, 1995
BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical propertiesM G Hunter, L Bawden, D Brotherton, et al.Casopis Lekaru Ceskych|January 8, 1997
Towards gene therapy of Hurler syndromeL J Fairbairn, L S Lashford, E Spooncer, et al.Pageof 29